<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ibogaine, an <z:chebi fb="13" ids="22315">alkaloid</z:chebi> derived from the African shrub Tabernanthe iboga, has shown promising anti-addictive properties in animals </plain></SENT>
<SENT sid="1" pm="."><plain>Anecdotal evidence suggests that ibogaine is also anti-addictive in humans </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, it alleviates drug craving and impedes relapse of drug use </plain></SENT>
<SENT sid="3" pm="."><plain>Although not licensed as therapeutic drug, and despite evidence that ibogaine may disturb the rhythm of the heart, this <z:chebi fb="13" ids="22315">alkaloid</z:chebi> is currently used as an anti-<z:mp ids='MP_0002555'>addiction</z:mp> drug in alternative medicine </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we report that therapeutic concentrations of ibogaine reduce currents through human <z:chebi fb="91" ids="25698">ether</z:chebi>-a-go-go-related gene <z:chebi fb="120" ids="26216">potassium</z:chebi> channels </plain></SENT>
<SENT sid="5" pm="."><plain>Thereby, we provide a mechanism by which ibogaine may generate life-threatening <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
</text></document>